Two well-known, Rhode Island executives with expertise in medical innovation told the Interstate 195 Redevelopment District Commission Monday they want to create a new center to attract talent and spur business creation.
Medley Genomics, a life sciences startup out of Brown University, has received $250,000 in seed funding from the Slater Technology Fund to build partnerships and demonstrate its concept with collaborators.
(Updated, Dec. 19, 4:40 p.m.)
EpiVax Inc. is part of a team that has been awarded a $1.87 million grant from Department of Defense’s Defense Threat Reduction Agency to develop an effective vaccine against a bacterium that leads to melioidosis, a tropical disease that is resistant to many antibiotics.
(Updated 9:23 a.m. and 4:23 p.m.)
The I-195 Redevelopment District Commission authorized a series of incentives Monday to attract Wexford Science & Technology LLC, as well as the Cambridge Innovation Center, to two prime parcels of the former highway land.